Brief: Mankind Pharma Acquires Panacea Biotec’s Domestic Formulation Brands For India And Nepal
28/02/2022 14:22
Feb 28 (Reuters) - Panacea Biotec Ltd PNCA.NS :
* MANKIND PHARMA ACQUIRES CO’S DOMESTIC FORMULATION BRANDS
FOR
INDIA AND NEPAL
* DEAL FOR 18.72 BILLION RUPEES
Further company coverage: PNCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility